Eli Lilly & Co. (LLY)
1074.87
-6.13
(-0.57%)
USD |
NYSE |
Jan 13, 09:58
Eli Lilly Market Cap: 962.03B for Jan. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 173.47B |
| Regeneron Pharmaceuticals, Inc. | 79.31B |
| Adverum Biotechnologies, Inc. | 96.26M |
| Viking Therapeutics, Inc. | 3.459B |
| Moderna, Inc. | 14.41B |
Market Cap Related Metrics
| PE Ratio | 53.16 |
| PS Ratio | 16.49 |
| PEG Ratio | 0.4387 |
| Price to Book Value | 40.43 |
| Price to Free Cash Flow | 152.25 |
| Price | 1074.87 |
| Earnings Yield | 1.88% |
| PEGY Ratio | 0.4367 |
| Operating PE Ratio | 37.13 |
| Normalized PE Ratio | 47.61 |